|
Completed
|
NCT04485546 -
Study to Evaluate OXERVATEâ„¢ in Patients With Stage 1 Neurotrophic Keratitis
|
Phase 4 |
|
Completed
|
NCT04552730 -
Nerve Growth Factor for the Treatment of Cornea Disease
|
|
|
Recruiting
|
NCT04276558 -
REC 0/0559 Eye Drops for Treatment of Moderate and Severe Neurotrophic Keratitis in Adult Patients
|
Phase 2 |
|
Recruiting
|
NCT04573647 -
OCT Evaluation of Neurotrophic Ulcer Following Treatment With Oxervate
|
|
|
Completed
|
NCT04820010 -
Topical Insulin - Utility and Results in Neurotrophic Keratopathy in Stages 2 and 3
|
|
|
Recruiting
|
NCT04627571 -
Corneal Nerves After Treatment With Cenegermin
|
|
|
Enrolling by invitation
|
NCT05758753 -
QST for Corneal Nerve Function
|
N/A |
|
Terminated
|
NCT05809245 -
Corneal Neurotization as a Treatment for Neurotrophic Keratopathy
|
N/A |
|
Withdrawn
|
NCT05321251 -
Topical Insulin Drops for the Treatment of Neurotrophic Keratopathy.
|
Phase 2/Phase 3 |
|
Terminated
|
NCT03037450 -
Miniinvasive Corneal Neurotization. A Pilot Study.
|
N/A |
|
Not yet recruiting
|
NCT06364657 -
Differences in Corneal Structure and Function in Patients With Sjogrens vs. Non-Sjogrens Dry Eye
|
|
|
Recruiting
|
NCT05566717 -
An Investigator-Initiated Study to Assess the Association of Diabetic Retinopathy Severity Scale (DRSS) With Level of Decreased Corneal Sensitivity
|
|
|
Not yet recruiting
|
NCT02707120 -
Efficacy and Safety of Plasma Rich in Growth Factors (PRGF-Endoret) Eye-drops in the Treatment of Neurotrophic Keratitis
|
Phase 4 |
|
Completed
|
NCT01756456 -
Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis.
|
Phase 1/Phase 2 |
|
Completed
|
NCT02227147 -
Evaluation of Efficacy of 20 µg/ml rhNGF New Formulation (With Anti-oxidant) in Patients With Stage 2 and 3 NK
|
Phase 2 |
|
Recruiting
|
NCT05552261 -
DEFENDO Long Term Follow-up Study in Stage 1 NK Patients
|
|
|
Recruiting
|
NCT04909450 -
Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects
|
Phase 1/Phase 2 |
|
Active, not recruiting
|
NCT06411145 -
Open-label Trial to Evaluate Efficacy and Safety of rhNGF on Corneal Thickness Via AS-OCT in Neurotrophic Keratitis
|
Phase 4 |